08:37 AM EST, 12/03/2024 (MT Newswires) -- GE HealthCare Technologies ( GEHC ) said Tuesday it has submitted a 510(k) application required for commercial distribution of medical products to the US Food and Drug Administration for its CleaRecon DL deep learning technology.

The company said the system is designed to improve the quality of cone-beam computed tomography images using artificial intelligence-based 3D reconstruction.

The company also said it is also introducing OnWatch Predict, which is designed to monitor the performance of interventional image-guided systems, allowing clinicians to arrange for service before a problem occurs.